The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 03, 2019

Filed:

Jun. 24, 2015
Applicant:

Instytut Biotechnologii I Anty-biotyków, Warsaw, PL;

Inventors:

Violetta Sączyńska, Warsaw, PL;

Agnieszka Romanik, Ostrów Mazowiecka, PL;

Katarzyna Florys, Iwaniska, PL;

Violetta Cecuda-Adamczewska, Warsaw, PL;

Malgorzata Kęsik-Brodacka, Warsaw, PL;

Grażyna Plucienniczak, Warsaw, PL;

Andrzej Plucienniczak, Warsaw, PL;

Piotr Borowicz, Warsaw, PL;

Natalia Lukasiewicz, Warsaw, PL;

Iwona Sokolowska, Warsaw, PL;

Diana Mikiewicz, Warsaw, PL;

Agnieszka Sobolewska, Warsaw, PL;

Piotr Baran, Warsaw, PL;

Józef Kapusta, Swarzedz, PL;

Michal Odrowąż-Sypniewski, Warsaw, PL;

Anna Bierczy{dot over (n)}ska-Krzysik, Warsaw, PL;

Zenon Minta, Pulawy, PL;

Krzysztof Śmietanka, Pulawy, PL;

Monika Olszewska, Chojnów, PL;

Boguslaw Szewczyk, Gdańsk, PL;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/00 (2006.01); A61K 39/12 (2006.01); C07K 16/10 (2006.01); A61K 39/145 (2006.01); C07K 14/005 (2006.01);
U.S. Cl.
CPC ...
A61K 39/145 (2013.01); A61K 39/12 (2013.01); C07K 14/005 (2013.01); C07K 16/1018 (2013.01); A61K 2039/543 (2013.01); A61K 2039/545 (2013.01); A61K 2039/552 (2013.01); A61K 2039/55505 (2013.01); C12N 2760/16122 (2013.01); C12N 2760/16134 (2013.01); C12N 2760/16151 (2013.01); C12N 2760/16171 (2013.01);
Abstract

The invention relates to an influenza viruses hemagglutinin protein as a vaccine antigen against influenza viruses, in particular to a protein being a fragment of H5 hemagglutinin from highly pathogenic avian influenza virus (HPAIV) H5N1 strain, expressed in a bacterial expression system. The protein according to the invention is a potential ingredient of an anti-HPAIV H5N1 vaccine, administered to chickens parenterally or through mucous membranes in the presence of adjuvants. The object of the invention is also a method of obtaining the vaccine protein.


Find Patent Forward Citations

Loading…